# Stage 6 — Patient Flow / Queue Production Readiness Record

**Date:** 2026-08-28
**Status:** CLOSED — PRODUCTION READY (STAGE SCOPE)
**Application commit:** `cfd86cc7aeb2dfc1f2b457f8b28ceac235b8b6fd`
**Production deployment:** `dpl_E57Dwvz2YGSvi5isCv1z4iVuk51U`

## Scope

Stage 6 reconciles the existing Patient Flow / Queue surface with the Global UX/IA authority without creating a parallel Queue, Patient Journey, Workspace, tenant, or permission architecture.

## Final gates

| Gate | Evidence | Status |
|---|---|---|
| Repository / UX / IA / AJM / PJ inspection | Stage 0–5 + AJM + PJ + UX/IA + current domain code | PASS |
| Supabase Patient Flow permissions | Live production verification | PASS |
| Automatic role grants | Live production verification: 0 | PASS |
| Canonical visit/session states | Live `clinic_visit_sessions` verification | PASS |
| Lockfile / dependency install | UX Stages 0–6 CI run #58 | PASS |
| TypeScript | UX Stages 0–6 CI run #58 | PASS |
| I18N audit + parity | UX Stages 0–6 CI run #58 | PASS |
| Stage 5 audits | UX Stages 0–6 CI run #58 | PASS |
| Stage 6 Patient Flow audit | UX Stages 0–6 CI run #58 | PASS |
| Stage 6 changed-surface ESLint | UX Stages 0–6 CI run #58 | PASS |
| Production build | UX Stages 0–6 CI run #58 | PASS |
| Production Candidate Handoff | GitHub run #5 / `33204734169` | PASS |
| Vercel production deployment | `dpl_E57Dwvz2YGSvi5isCv1z4iVuk51U` | READY |
| Production protected-route runtime | `/patient-flow`, `/patient-flow/operations`, `/patient-flow/clinical`, `/patient-flow/administrative` | PASS — unauthenticated requests correctly resolve to `/login` |
| Production runtime errors | Vercel runtime logs for deployment | No errors found in verification window |
| Deployment workflow | `.github/workflows/production-gated-deploy.yml` | PASS — Vercel Git Integration, no Actions Vercel secrets required |
| Documentation | Stage 6 implementation/readiness/findings records | COMPLETE |

## GitHub validation

The final engineering gate passed all blocking Stage 6 checks. The full-repository ESLint output contains pre-existing unrelated findings; these remain diagnostic and were not suppressed. The Stage 6 changed surface passed its blocking ESLint gate.

## Vercel / Production verification

Vercel deployed the exact `main` commit `cfd86cc7aeb2dfc1f2b457f8b28ceac235b8b6fd` to the production target and reported `READY`. The canonical production alias is `core-system-clinic.vercel.app`.

Unauthenticated runtime probes against the Patient Flow root and all three explicit contexts returned the application login surface with `x-matched-path: /login`, proving that the protected Patient Flow routes are live and enforcing authentication rather than exposing an error or 404.

Vercel runtime logs for the production deployment showed no runtime errors in the verification window.

## Findings disposition

No Stage 6-owned unresolved blocker remains.

The existing production dependency audit reports 14 vulnerabilities (1 moderate, 13 high), including findings in transitive `adm-zip`, `js-yaml`, `nanoid`, `next`, `postcss`, and `sharp`. These pre-date Stage 6, are not introduced by Patient Flow, and remain explicitly recorded as **S6-SEC-001 / non-Stage-6 security debt** for the dependency/security workstream. They are not hidden, suppressed, or represented as a Stage 6 defect.

## Closure decision

All Stage 6-owned implementation, architecture, CI, Supabase, deployment, and production protected-route gates have passed. The previous Vercel credential blocker was removed by reconciling the workflow with the existing Vercel Git Integration.

**Stage 6 is CLOSED / Production Ready for its defined Patient Flow / Queue scope.**

Future work must not reopen Stage 6 unless a regression is discovered in its owned surface.
